CHIASMA, INC (CHMA) [Rocket]

In millions, except per share items	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues [+]	1.1	0.0	0.0	0.0	0.0	0.0	13.2	73.1
Licensing							13.2	73.1
Royalties								26.5
Revenue growth						-100.0%	-82.0%
Cost of goods sold	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	1.0	0.0	0.0	0.0	0.0	0.0	13.2	73.1
Gross margin	94.5%						100.0%	100.0%
Selling, general and administrative [+]	44.9	15.1	10.0	9.1	21.8	16.5	3.5	8.1
General and administrative				9.1	21.8	16.5
Research and development	26.8	22.5	22.4	17.9	31.3	19.0	11.5	26.5
EBITDA [+]	-70.5	-37.5	-32.2	-26.9	-52.7	-35.2	-1.6	38.9
EBITDA growth	87.8%	16.4%	19.7%	-48.9%	49.5%	2162.3%	-104.0%
EBITDA margin	-6372.2%						-11.8%	53.2%
Depreciation and amortization	0.2	0.1	0.1	0.2	0.4	0.2	0.3	0.3
EBIT [+]	-70.6	-37.6	-32.3	-27.1	-53.1	-35.4	-1.8	38.6
EBIT growth	88.0%	16.2%	19.3%	-49.0%	49.9%	1837.0%	-104.7%
EBIT margin	-6387.8%						-13.9%	52.8%
Non-recurring items				1.0	8.2
Interest expense, net [+]	5.2	-1.5	-1.0	-0.9	-0.8	-0.1	0.0	0.0
Interest expense	5.9			0.1	0.3	0.3	0.0	1.1
Interest income	0.7	1.5	1.0	0.9	0.8	0.1	0.0	0.0
Other income (expense), net	1.2			-0.1	0.0	-0.1	0.0	-0.1
Pre-tax income	-74.7	-36.0	-31.3	-27.4	-60.8	-35.7	-1.8	37.4
Income taxes	0.1	0.3	0.0	-0.6	0.3	0.2	0.2	1.2
Tax rate			0.1%	2.2%				3.3%
Net income	-74.8	-36.3	-31.3	-26.8	-61.1	-36.2	-2.9	-5.4
Net margin	-6761.2%						-22.1%	-7.3%

Basic EPS [+]	($1.43)	($1.06)	($1.28)	($1.10)	($2.51)	($3.25)	($66.22)	($125.28)
Growth	34.8%	-17.1%	16.4%	-56.2%	-22.6%	-95.1%	-47.1%
Diluted EPS [+]	($1.43)	($1.06)	($1.28)	($1.10)	($2.51)	($3.25)	($66.22)	($125.28)
Growth	34.8%	-17.1%	16.4%	-56.2%	-22.6%	-95.1%	-47.1%

Shares outstanding (basic) [+]	52.2	34.2	24.4	24.4	24.3	11.2	0.0	0.0
Growth	52.7%	40.2%	0.1%	0.2%	118.1%	25235.6%	2.9%
Shares outstanding (diluted) [+]	52.2	34.2	24.4	24.4	24.3	11.2	0.0	0.0
Growth	52.7%	40.2%	0.1%	0.2%	118.1%	25235.6%	2.9%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.